35 results on '"Maurer, Matthew"'
Search Results
2. Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti–CD20-based Biological Therapy
3. A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts
4. Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study
5. Abstract 18315: The Association of Age and Pulse Pressure to Serious Adverse Events in the SPRINT Trial
6. Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose‐adjusted EPOCH plus rituximab
7. Clinical heterogeneity of diffuse large B cell lymphoma following failure of front‐line immunochemotherapy
8. Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma
9. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011
10. Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States
11. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ
12. Plasma immune analytes in patients with epithelial ovarian cancer
13. Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma
14. Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma
15. PatternCNV: a versatile tool for detecting copy number changes from exome sequencing data
16. Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma
17. Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein-10 predicts inferior prognosis in untreated diffuse large B-cell lymphoma
18. Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: Results from two independent cohorts
19. A Secreted PTEN Phosphatase That Enters Cells to Alter Signaling and Survival
20. A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma
21. Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: A clinic-based case-control study
22. Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma
23. Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients
24. Inherited genetic variation and overall survival following follicular lymphoma
25. Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma
26. Smoking, Alcohol Use, Obesity, and Overall Survival From Non-Hodgkin Lymphoma: A Population-Based Study
27. Complementary and alternative medicine use among long-term lymphoma survivors: A pilot study
28. Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a
29. Low-Dose, Single-Agent Temsirolimus for Relapsed Mantle Cell Lymphoma: A Phase 2 Trial in the North Central Cancer Treatment Group
30. A Phase 2 Study of Gemcitabine and Epirubicin for the Treatment of Pleural Mesothelioma: A North Central Cancer Treatment Study, N0021
31. A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma
32. Topotecan and Paclitaxel in Previously Treated Patients with Relapsed Small Cell Lung Cancer: Phase II Trial of the North Central Cancer Treatment Group
33. Prognostic Analysis for Survival in Adult Solid Organ Transplant Recipients With Post-Transplantation Lymphoproliferative Disorders
34. Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial
35. Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.